BiomX
PHGE
10 hedge funds and large institutions have $7.81M invested in BiomX in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
26% more capital invested
Capital invested by funds: $6.2M → $7.81M (+$1.62M)
11% more funds holding
Funds holding: 9 → 10 (+1)
0.02% more ownership
Funds ownership: 0.16% → 0.18% (+0.02%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$3.28M |
| 2 |
Barclays
London,
United Kingdom
|
+$88.7K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$17.3K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$3.71K |
| 5 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$3.57K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$20.5K |
| 2 |
Millennium Management
New York
|
-$8.89K |
| 3 |
JF
Jump Financial
Chicago,
Illinois
|
-$8.64K |
PHGE Hedge Fund Activity: Q2 2024 in Review
10 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in BiomX (PHGE) for Q2 2024, worth a combined $7.81M — up 26% from $6.2M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new PHGE positions and 2 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.
The largest buyer was OrbiMed, adding an estimated $3.28M. The largest seller was Renaissance Technologies, cutting an estimated $20.5K.
- 10 institutional investors held BiomX (PHGE) as of Q2 2024, up from 9 in Q1 2024.
- Funds reported $7.81M of BiomX stock for Q2 2024, up 26% quarter-over-quarter.
- 3 funds opened new BiomX positions in Q2 2024 and 2 closed out, a net change of +1 holder.
- The largest BiomX buyer in Q2 2024 was OrbiMed, an estimated $3.28M added.
- The largest BiomX seller in Q2 2024 was Renaissance Technologies, an estimated $20.5K sold.
Based on aggregated 13F filings for Q2 2024.